CoChat

Targeting the Wnt/β-catenin signaling pathway in cancer

Open access
Zhang, Ya, Wang, Xin · 2020 · Journal of Hematology & Oncology

The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.

Abstract

The aberrant Wnt/β-catenin signaling pathway facilitates cancer stem cell renewal, cell proliferation and differentiation, thus exerting crucial roles in tumorigenesis and therapy response. Accumulated investigations highlight the therapeutic potential of agents targeting Wnt/β-catenin signaling in cancer. Wnt ligand/ receptor interface, β-catenin destruction complex and TCF/β-catenin transcription complex are key components of the cascade and have been targeted with interventions in preclinical and clinical evaluations. This scoping review aims at outlining the latest progress on the current approaches and perspectives of Wnt/β-catenin signaling pathway targeted therapy in various cancer types. Better understanding of the updates on the inhibitors, antagonists and activators of Wnt/β-catenin pathway rationalizes innovative strategies for personalized cancer treatment. Further investigations are warranted to confirm precise and secure targeted agents and achieve optimal use with clinical benefits in malignant diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13045-020-00990-3

Cites

165 of 165 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic representation of activated and inhibited Wnt/β-catenin pathway. “WNT ON state”: Upon ligation of Wnts to their receptors composed of frizzled proteins and LRP5/6, the cytoplasmic protein DVL is activated and induces the suppression of GSK3β. Subsequently, stabilized β-catenin translocates into the nucleus and binds to TCF/LEF transcription factors to lead to target gene transcription. “WNT OFF state”: In the absence of WNT ligand, the destruction complex of β-catenin, a tertiary complex formed by AXIN, CK1α, GSK3β and APC, phosphorylates β-catenin, which subsequently undergoes the ubiquitin-proteasomal degradation
Fig. 1 Schematic representation of activated and inhibited Wnt/β-catenin pathway. “WNT ON state”: Upon ligation of Wnts to their receptors composed of frizzled proteins and LRP5/6, the cytoplasmic protein DVL is activated and induces the suppression of GSK3β. Subsequently, stabilized β-catenin translocates into the nucleus and binds to TCF/LEF transcription factors to lead to target gene transcription. “WNT OFF state”: In the absence of WNT ligand, the destruction complex of β-catenin, a tertiary complex formed by AXIN, CK1α, GSK3β and APC, phosphorylates β-catenin, which subsequently undergoes the ubiquitin-proteasomal degradationCC BY · PubMed Central
Fig. 2 Hallmarks of diverse categories of Wnt/β-catenin targeted agents in cancer
Fig. 2 Hallmarks of diverse categories of Wnt/β-catenin targeted agents in cancerCC BY · PubMed Central
Fig. 3 Graphic overview of Wnt/β-catenin signaling pathway targeted interventions in cancer studies. Promising therapeutics targeting Wnt ligand/ receptor interface, β-catenin destruction complex and TCF/β-catenin transcription complex are investigated in preclinical and clinical evaluations
Fig. 3 Graphic overview of Wnt/β-catenin signaling pathway targeted interventions in cancer studies. Promising therapeutics targeting Wnt ligand/ receptor interface, β-catenin destruction complex and TCF/β-catenin transcription complex are investigated in preclinical and clinical evaluationsCC BY · PubMed Central
Fig. 4 The schematic model of abnormal activation of the Wnt/β-catenin pathway promoting cancer stem cell progression and thus leading to the deterioration and metastasis of cancer
Fig. 4 The schematic model of abnormal activation of the Wnt/β-catenin pathway promoting cancer stem cell progression and thus leading to the deterioration and metastasis of cancerCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 165 references

Research works printed but not linked: 1

  1. Amado N, Predes D, Fonseca B, Cerqueira D, Reis A, Dudenhoeffer A, Borges H, Mendes F, Abreu J. Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-catenin signaling pathway. J Biol Chem. 2014b;289(51):35456–67. · DOI

Cited by

See all 1,431

Metadata

Authors
Zhang, Y., & Wang, X.
Affiliations
Shandong University (CN)
Corresponding author
Wang, Xin
Venue
Journal of Hematology & Oncology
Published
2020-12
Volume
13
Issue
1
Pages
165-165
ISSN
1756-8722 (ISSN-L)
OpenAlex
W3108389912
Cited by
1,431
References
165
Citations by year
2026: 140 · 2025: 298 · 2024: 363 · 2023: 312 · 2022: 238 · 2021: 79 · 2020: 1
FWCI
15.17
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Hematology & Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (No.82000195)
  • National Natural Science Foundation (No. 81270598, No. 81473486, No. 81770210)
  • Key Research and Development Program of Shandong Province (No.2018CXGC1213)
  • Technology Development Projects of Shandong Province (No. 2017GSF18189)
  • Taishan Scholars Program of Shandong Province (No.tsqn201909184)
  • Academic promotion programme of Shandong First Medical University (2020RC007)
  • Shandong Provincial Hospital Youth Talent Plan
  • Shandong Provincial Hospital Research Incubation Fund
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
Keywords
Wnt/β-catenin signaling, cancer stem cells, targeted cancer therapy, β-catenin destruction complex, Wnt inhibitors, precision oncology, carcinogenesis
MeSH terms
Animals, Antineoplastic Agents, Humans, Neoplasms, Neoplastic Stem Cells, Wnt Proteins, beta Catenin, Molecular Targeted Therapy, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting the Wnt/β-catenin signaling pathway in cancer. https://app.cochat.ai/papers/10.1186/s13045-020-00990-3
The paper
Zhang, Y., & Wang, X. (2020). Targeting the Wnt/β-catenin signaling pathway in cancer. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-020-00990-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.